Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance & Commercialisation Path to Improve Clinical Decision Making & Patient Outcomes
The 13th Clinical Biomarkers & CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress towards commercialisation.